18F-GE180, a radioligand for the TSPO protein: not ready for clinical trials in multiple sclerosis
- 8 May 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 47 (10), 2242-2243
- https://doi.org/10.1007/s00259-020-04844-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Anatomy of 18F-GE180, a failed radioligand for the TSPO proteinEuropean Journal of Nuclear Medicine and Molecular Imaging, 2020
- In Response to Letter from Fregonara et al. 2019Molecular Imaging & Biology, 2019
- A quantitative neuropathological assessment of translocator protein expression in multiple sclerosisBrain, 2019
- Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey MatterMolecular Imaging & Biology, 2019
- TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing–remitting multiple sclerosisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Sifting through the surfeit of neuroinflammation tracersJournal of Cerebral Blood Flow & Metabolism, 2017
- TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosisEJNMMI Research, 2017
- [11C]PBR‐28 positron emission tomography in multiple sclerosis: Neuroinflammation or otherwise?Annals of Neurology, 2017
- Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brainEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Detection of Microglial Activation in an Acute Model of Neuroinflammation Using PET and Radiotracers11C-(R)-PK11195 and18F-GE-180Journal of Nuclear Medicine, 2014